The effect of WT1 expression on the prognosis of allogeneic hematopoietic stem cell transplantation in acute leukemia

被引:0
|
作者
蒋冰倩 [1 ]
机构
[1] Hematol & Bone Marrow Transplant Center,1st Affil Hosp,Med Sch,Zhejiang Univ
关键词
DFS; The effect of WT1 expression on the prognosis of allogeneic hematopoietic stem cell transplantation in acute leukemia; WT;
D O I
暂无
中图分类号
R733.71 [急性白血病];
学科分类号
100214 ;
摘要
Objective To study the effect of WT1 expression on the prognosis of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute leukemia (AL) and its significance as molecular marker to dynamically monitor minimal residual disease (MRD). Methods Retrospectively analyzed those AL patients who underwent
引用
收藏
页码:56 / 57
页数:2
相关论文
共 50 条
  • [1] Expression of RHAMM and WT1 before and after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
    Casalegno-Garduno, R.
    Meier, C.
    Mani, J.
    Borchert, K.
    Hilgendorf, I
    Gross, Y.
    Filipowska, A.
    Koczan, D.
    Spitschak, A.
    Linnebacher, M.
    Schmitt, A.
    Puetzer, B. M.
    Schmitt, M.
    ONKOLOGIE, 2011, 34 : 84 - 84
  • [2] Clinical significance of the expression of WT1 gene before Allogeneic hematopoietic stem cell transplantation in AML patients
    Rostami, S.
    Chahardouli, B.
    Ghandfroush, N. Alizad
    Jahani, M.
    Mousavi, S. A.
    Bahar, B.
    Zadeh, H. Kamran
    Vaezi, M.
    Alimoghaddam, K.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S449 - S449
  • [3] Allogeneic hematopoietic stem cell transplantation for acute leukemia
    Appelbaum, FR
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : 114 - 123
  • [4] Measurable Residual Disease Assay with WT1 Expression in Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation; Optimal Threshold, Time Points, and Candidates
    Cho, Byung Sik
    Min, Gi June
    Kim, Heeje
    Yoon, Seug Yun
    Park, Sung-Soo
    Park, Silvia
    Yahng, Seung-Ah
    Jeon, Young-Woo
    Shin, Seung-Hwan
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    BLOOD, 2018, 132
  • [5] Allogeneic hematopoietic stem cell transplantation for patients with acute leukemia
    Yan Chen
    Yajing Xu
    Gan Fu
    Yi Liu
    Jie Peng
    Bin Fu
    Xiaoyu Yuan
    Hongya Xin
    Yan Zhu
    Qun He
    Dengshu Wu
    Yigang Shu
    Xiaolin Li
    Xielan Zhao
    Fangping Chen
    ChineseJournalofCancerResearch, 2013, 25 (04) : 389 - 396
  • [6] Allogeneic hematopoietic stem cell transplantation for patients with acute leukemia
    Chen, Yan
    Xu, Yajing
    Fu, Gan
    Liu, Yi
    Peng, Jie
    Fu, Bin
    Yuan, Xiaoyu
    Xin, Hongya
    Zhu, Yan
    He, Qun
    Wu, Dengshu
    Shu, Yigang
    Li, Xiaolin
    Zhao, Xielan
    Chen, Fangping
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (04) : 389 - 396
  • [7] Allogeneic hematopoietic stem cell transplantation for acute lymphocytic leukemia
    Ren, HY
    Chen, H
    Huang, XJ
    Xu, LP
    Zhang, Y
    Liu, DH
    Guo, NL
    Lu, DP
    BONE MARROW TRANSPLANTATION, 2003, 31 : S174 - S174
  • [8] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
    Choi, Yunsuk
    Choi, Eun-Ji
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Jo, Jae-Cheol
    Park, Han-Seung
    Lee, Yoo Jin
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    CLINICAL TRANSPLANTATION, 2021, 35 (03)
  • [9] Significance of WT1 and multiparameter flow cytometry assessment in patients with chronic myelomonocytic leukemia receiving allogeneic hematopoietic stem cell transplantation
    Pan, Xinan
    Gao, Mengge
    Sun, Yuqian
    Zhou, Yang
    Wang, Ke
    Wang, Yu
    Xu, Lanping
    Zhang, Xiaohui
    Huang, Xiaojun
    Zhao, Xiao-Su
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (03) : 510 - 517
  • [10] KINETICS OF WT1 OVER-EXPRESSION IN ACUTE MYELOID LEUKEMIA PATIENTS WHO RECEIVED STANDARD CHEMOTHERAPY OR UNDERWENT ALLOGENEIC STEM CELL TRANSPLANTATION
    Eisa, N.
    Shamaa, S.
    Khalaf, M.
    Azmy, E.
    Agm, A.
    Samra, M.
    Emarah, Z.
    HAEMATOLOGICA, 2016, 101 : 681 - 681